Document is current

Any future updates will be listed below

Effects of ertugliflozin on kidney composite outcomes, renal function and albuminuria in patients with type 2 diabetes mellitus: an analysis from the randomised VERTIS CV trial

Crossref DOI link: https://doi.org/10.1007/s00125-021-05407-5

Published Online: 2021-03-04

Published Print: 2021-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark